Bioventus reported cash from operations of $19.87M and free cash flow of $18.91M for the quarter ended Jun 2026, down 23.4% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Apr2021 | Jul2021 | Oct2021 | Dec2021 | Apr2022 | Jul2022 | Oct2022 | Dec2022 | Apr2023 | Jul2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | -2.27M | -0.03M | -14.81M | -8.01M | -145.70M | -44.87M | -174.45M | -4.73M | -8.79M | -7.66M | -6.38M | -34.22M | -5.85M | -0.60M | -3.32M | 9.27M | 4.01M | 17.32M | 3.95M | 36.20M | ||||||
| Share-based CompensationStock Comp. | 5.94M | 6.11M | 4.89M | 4.62M | 4.65M | 3.43M | 1.85M | -2.73M | 1.83M | 1.77M | 2.99M | 5.78M | 2.49M | 2.02M | 2.41M | 3.64M | 3.18M | 3.44M | 3.26M | 5.04M | ||||||
| Deferred Taxes | -0.72M | -8.05M | -17.02M | -10.68M | -7.19M | -11.77M | -2.66M | -0.88M | 1.16M | 0.08M | -8.18M | -0.51M | 3.21M | 0.04M | 0.04M | 0.14M | -1.13M | 0.14M | -22.29M | |||||||
| Cash from Discontinued OperationsCash from Discont. Ops | -0.86M | -1.27M | -2.17M | |||||||||||||||||||||||
| Gains from Investment SecuritiesGains Investment | 0.65M | -0.46M | 0.27M | 0.27M | 0.28M | 0.28M | 0.29M | 0.24M | -0.10M | 0.29M | 0.29M | 0.30M | 0.48M | 0.34M | ||||||||||||
| Asset Writedowns and ImpairmentWritedown | 0.22M | 1.15M | 1.35M | 124.70M | 10.29M | 78.61M | -0.44M | -1.33M | -0.98M | 31.87M | 2.03M | 2.46M | 0.65M | 0.19M | 0.10M | 0.31M | 0.23M | -0.09M | ||||||||
| Change in Working CapitalChange Working Cap. | 0.71M | 1.13M | ||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 3.78M | 6.90M | -4.42M | 25.57M | -8.32M | 4.83M | -13.16M | 1.83M | -7.92M | 9.19M | 1.96M | 19.98M | -17.06M | 5.79M | -9.00M | 13.63M | -1.82M | -1.89M | -7.32M | 17.94M | ||||||
| Change in InventoryChange Inventory | 2.42M | -1.69M | -0.33M | 2.94M | 6.01M | 10.00M | 5.29M | 7.78M | 1.05M | -8.13M | 4.07M | 4.29M | 2.52M | 5.56M | 1.88M | 2.81M | -0.29M | -12.97M | 2.65M | -2.96M | ||||||
| Change in Accured ExpensesChange Accured Exp. | 4.33M | 10.96M | -7.92M | 25.66M | -35.16M | 14.31M | 2.33M | 12.43M | -25.83M | 5.79M | -7.33M | 29.88M | -21.33M | 16.62M | -39.10M | 16.42M | 7.31M | -4.44M | -15.37M | 3.82M | ||||||
| Other Working Capital ChangesOther WC Changes | 0.71M | 2.76M | 1.53M | -4.67M | 1.80M | -8.32M | 2.13M | -0.17M | -2.75M | 2.76M | 1.40M | 0.08M | -6.33M | 7.38M | -0.78M | -0.49M | -1.25M | 4.20M | -0.52M | -0.99M | ||||||
| Cash from OperationsCash from Ops. | 10.59M | 13.12M | -21.02M | 2.94M | -0.70M | 5.24M | 4.66M | 10.79M | -8.31M | 10.37M | -6.00M | 15.16M | 10.32M | 19.32M | -19.33M | 25.94M | 30.10M | 37.97M | 8.93M | 19.87M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | ||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 8.52M | 11.69M | 12.48M | 12.38M | 13.59M | 16.94M | 16.47M | 14.60M | 13.83M | 12.46M | 11.79M | 13.09M | 12.28M | 12.40M | 11.87M | 12.05M | 11.40M | 11.69M | 11.21M | 10.95M | ||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital ExpendituresCapex | 1.93M | 8.95M | 2.96M | 2.03M | 1.65M | -5.16M | 3.56M | 1.40M | 2.04M | 0.37M | 0.29M | 0.08M | 0.06M | 0.57M | 0.83M | 0.68M | 0.47M | 0.58M | 0.57M | 0.96M | ||||||
| Acquisitions | -45.79M | 262.87M | 0.24M | -0.01M | 104.61M | |||||||||||||||||||||
| Divestments | -104.84M | -11.51M | 46.40M | -46.40M | ||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -13.19M | -221.28M | -4.67M | -52.02M | -56.33M | -3.40M | -15.07M | 45.01M | -2.04M | -0.59M | -1.00M | -0.08M | -0.06M | 24.10M | -0.83M | -1.37M | -0.47M | -0.58M | -0.57M | -2.46M | ||||||
| Financing Activities | ||||||||||||||||||||||||||
| Other financing activitiesOther financing | -0.01M | -0.01M | 0.02M | -0.01M | -0.04M | -0.13M | -0.17M | 4.00M | -0.18M | -0.19M | -0.19M | 1.74M | -0.20M | -0.21M | -0.21M | -0.21M | -0.22M | -0.24M | ||||||||
| Cash from Financing ActivitiesCash from Financing | -4.35M | 176.31M | 9.21M | 7.66M | 50.65M | -5.44M | 27.38M | -62.25M | 8.23M | -0.01M | -4.24M | -7.84M | 0.36M | -42.85M | 0.95M | -14.66M | -19.98M | -28.45M | -23.14M | -23.43M | ||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 0.42M | 0.89M | 2.08M | 2.18M | 0.48M | 1.08M | 0.08M | 0.14M | 0.40M | 0.16M | 0.18M | 0.61M | 0.55M | 1.10M | 0.15M | 1.32M | 0.10M | 0.51M | 0.12M | 0.85M | ||||||
| Dividend Payments | ||||||||||||||||||||||||||
| Dividends Paid - CommonDiv. Paid (Common) | 0.18M | |||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -0.21M | 0.15M | -0.07M | -0.22M | -0.24M | 1.05M | 0.46M | 0.24M | -0.44M | 0.37M | -0.54M | -0.42M | 0.47M | -2.06M | 0.43M | 0.20M | -0.39M | 0.13M | -0.61M | -0.37M | ||||||
| Change in Cash | -7.15M | -31.70M | -16.56M | -41.65M | -6.62M | -2.54M | 15.27M | -17.71M | -2.56M | 10.14M | -11.79M | 6.82M | 11.08M | -1.49M | -18.78M | 10.11M | 9.25M | 9.07M | -15.39M | -6.39M | ||||||
| Free Cash FlowFCF | 8.66M | 4.17M | -23.98M | 0.91M | -2.35M | 10.40M | 1.10M | 9.40M | -10.35M | 10.01M | -6.30M | 15.09M | 10.25M | 18.75M | -20.16M | 25.25M | 29.62M | 37.39M | 8.36M | 18.91M | ||||||
| Net Cash FlowNCF | -6.95M | -31.85M | -16.49M | -41.43M | -6.38M | -3.60M | 16.97M | -6.45M | -2.12M | 9.77M | -11.25M | 7.24M | 10.61M | 0.57M | -19.21M | 9.91M | 9.65M | 8.94M | -14.78M | -6.02M |